How many drugs treat Tinea capitis?

Drug Landscape tracks 5 marketed treatments for Tinea capitis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/tinea-capitis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Tinea capitis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tinea capitis (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Tinea capitis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Grifulvin V	GRISEOFULVIN	Johnson And Johnson	Tubulin Inhibiting Agent [EPC]	Solute carrier family 22 member 1	1962-01-01
FULVICIN P/G 330	GRISEOFULVIN, ULTRAMICROSIZE	CHARTWELL RX		Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin
GRISEOFULVIN	GRISEOFULVIN, MICROSIZE	COSETTE	Tubulin Inhibiting Agent [EPC]	Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin
GRISACTIN ULTRA	GRISEOFULVIN, ULTRAMICROCRYSTALLINE	WYETH AYERST		Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin
GRIFULVIN V	GRISEOFULVIN, MICROCRYSTALLINE	JOHNSON AND JOHNSON		Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

CHARTWELL RX · 1 drug in Tinea capitis
COSETTE · 1 drug in Tinea capitis
JOHNSON AND JOHNSON · 1 drug in Tinea capitis
Johnson And Johnson · 1 drug in Tinea capitis
WYETH AYERST · 1 drug in Tinea capitis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Tinea capitis:

Cite this brief

Drug Landscape (2026). Tinea capitis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/tinea-capitis. Accessed 2026-06-10.

Tinea capitis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing